SUPN MEXC RealStocks
Own real SUPN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:30:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Supernus, Inc. (SUPN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $28.98, with a market capitalization of $5.99B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $25.92 to $59.68. This page covers its latest market performance, valuation, price trends and company information.
$5.99B | |
$29.21 | |
$29.75 | |
$27.78 | |
$29.04 | |
2.41M | |
1.49M | |
-- | |
$59.68 | |
$25.92 | |
-- | |
2026-09-30 |
Supernus, Inc. (SUPN) last closed at $28.98 as of 2026-11-19 00:48:00, down 0.22% ($0.06) from the previous close of $29.04.
During the latest regular trading session, SUPN traded between $27.78 and $29.75, with a volume of 2.41M shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Supernus, Inc. (SUPN) moved from $27.62 to $28.98, representing a gain of 4.91% ($1.36).
The stock traded between $26.11 and $30.18 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 3.32 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 9.1%
SUPN is currently trading at $28.98, placing it 9.1% of the way from its 52-week low of $25.92 to its 52-week high of $59.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 778 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Supernus, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Nov 3, 2026 |
| Payment Date | Nov 6, 2026 |
| Dividend Per Share | $8.13 |
Eligible investors can buy real shares of Supernus, Inc. (SUPN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SUPN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SUPN shares and USD.
SUPN Shares to USD
1.00 SUPN shares = 28.976 USD
Calculations are estimates based on the latest available price and are for reference only.